Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Tóm tắt
Từ khóa
Tài liệu tham khảo
2016, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 1459, 10.1016/S0140-6736(16)31012-1
2016, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 1545, 10.1016/S0140-6736(16)31678-6
Burney, 2015, The global burden of chronic respiratory disease in adults, Int J Tuberc Lung Dis, 19, 10, 10.5588/ijtld.14.0446
Yáñez, 2014, Asthma in the elderly: what we know and what we have yet to know, World Allergy Organ J, 7, 8, 10.1186/1939-4551-7-8
Wurst, 2016, A comparison of COPD patients with and without ACOS in the ECLIPSE study, Eur Respir J, 47, 1559, 10.1183/13993003.02045-2015
de Marco, 2015, Asthma, COPD and overlap syndrome: a longitudinal study in young European adults, Eur Respir J, 46, 671, 10.1183/09031936.00008615
Sin, 2016, What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion, Eur Respir J, 48, 664, 10.1183/13993003.00436-2016
Caballero, 2008, Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study), Chest, 133, 343, 10.1378/chest.07-1361
Menezes, 2004, The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities, BMC Med Res Methodol, 4, 15, 10.1186/1471-2288-4-15
Vollmer, 2009, Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study, Eur Respir J, 34, 588, 10.1183/09031936.00164608
Quinn, 2005, Epidemiology of COPD
Vogelmeier, 2017, Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary, Eur Respir J, 49, 1750214, 10.1183/13993003.00214-2017
Quanjer, 2012, Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations, Eur Respir J, 40, 1324, 10.1183/09031936.00080312
Lamprecht, 2015, Determinants of underdiagnosis of COPD in national and international surveys, Chest, 148, 971, 10.1378/chest.14-2535
Soriano, 2009, Screening for and early detection of chronic obstructive pulmonary disease, Lancet, 374, 721, 10.1016/S0140-6736(09)61290-3
Pearce, 2000, Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood, Eur Respir J, 16, 420, 10.1183/9031936.00.16337700
Toelle, 1992, Toward a definition of asthma for epidemiology, Am Rev Respir Dis, 146, 633, 10.1164/ajrccm/146.3.633
Riiser, 2012, Does bronchial hyperresponsiveness in childhood predict active asthma in adolescence?, Am J Respir Crit Care Med, 186, 493, 10.1164/rccm.201112-2235OC
Pekkanen, 1999, Defining asthma in epidemiological studies, Eur Respir J, 14, 951, 10.1034/j.1399-3003.1999.14d37.x
Pattemore, 1990, The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms, Am Rev Respir Dis, 142, 549, 10.1164/ajrccm/142.3.549
2016, Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 1659, 10.1016/S0140-6736(16)31679-8
Tilert, 2013, Estimating the US prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007–2010, Respir Res, 14, 103, 10.1186/1465-9921-14-103
Johannessen, 2005, Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study, Thorax, 60, 842, 10.1136/thx.2005.043943
Pérez-Padilla, 2007, Impact of bronchodilator use on the prevalence of COPD in population-based samples, COPD, 4, 113, 10.1080/15412550701341012
Shirtcliffe, 2007, COPD prevalence in a random population survey: a matter of definition, Eur Respir J, 30, 232, 10.1183/09031936.00157906
Mohamed Hoesein, 2012, Spirometric thresholds for diagnosing COPD: 0·70 or LLN, pre- or post-dilator values?, COPD, 9, 338, 10.3109/15412555.2012.667851
Ko, 2008, Prevalence and risk factors of airflow obstruction in an elderly Chinese population, Eur Respir J, 32, 1472, 10.1183/09031936.00058708
Swanney, 2008, Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction, Thorax, 63, 1046, 10.1136/thx.2008.098483
Lindberg, 2006, Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking report from the Obstructive Lung Disease in Northern Sweden Studies, Respir Med, 100, 264, 10.1016/j.rmed.2005.04.029
Ware, 1996, A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity, Med Care, 34, 220, 10.1097/00005650-199603000-00003
Brauer, 2016, Ambient air pollution exposure estimation for the Global Burden of Disease 2013, Environ Sci Technol, 50, 79, 10.1021/acs.est.5b03709
Jerrett, 2009, Long-term ozone exposure and mortality, N Engl J Med, 360, 1085, 10.1056/NEJMoa0803894
Salomon, 2015, Disability weights for the Global Burden of Disease 2013 study, Lancet Glob Health, 3, e712, 10.1016/S2214-109X(15)00069-8
Stevens, 2016, Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement, Lancet, 388, e19, 10.1016/S0140-6736(16)30388-9
Burney, 2012, The use of ethnically specific norms for ventilatory function in African-American and white populations, Int J Epidemiol, 41, 782, 10.1093/ije/dys011
Soriano, 2009, Remember elephants and icebergs… ‘Your lung function should be here, but it is there!’, Eur Respir J, 33, 715, 10.1183/09031936.00001109
Halbert, 2006, Global burden of COPD: systematic review and meta-analysis, Eur Respir J, 28, 523, 10.1183/09031936.06.00124605
Masoli, 2004, The global burden of asthma: executive summary of the GINA Dissemination Committee report, Allergy, 59, 469, 10.1111/j.1398-9995.2004.00526.x
To, 2012, Global asthma prevalence in adults: findings from the cross-sectional world health survey, BMC Public Health, 12, 204, 10.1186/1471-2458-12-204
Burney, 2014, Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty—a BOLD analysis, Thorax, 69, 465, 10.1136/thoraxjnl-2013-204460
Bousquet, 2013, Pooling birth cohorts in allergy and asthma: European Union-funded initiatives—a MeDALL, CHICOS, ENRIECO, and GA2LEN joint paper, Int Arch Allergy Immunol, 161, 1, 10.1159/000343018
Kohansal, 2009, Investigating the natural history of lung function: facts, pitfalls, and opportunities, Chest, 135, 1330, 10.1378/chest.08-1750
Bilano, 2015, Global trends and projections for tobacco use, 1990–2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control, Lancet, 385, 966, 10.1016/S0140-6736(15)60264-1
Ng, 2014, Smoking prevalence and cigarette consumption in 187 countries, 1980–2012, JAMA, 311, 183, 10.1001/jama.2013.284692
2017, Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015, Lancet, 389, 1885, 10.1016/S0140-6736(17)30819-X
Buist, 2007, International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study, Lancet, 370, 741, 10.1016/S0140-6736(07)61377-4
Lee, 2012, Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease, PLoS One, 7, e37978, 10.1371/journal.pone.0037978
Shaheen, 1995, Do lower respiratory tract infections in early childhood cause chronic obstructive pulmonary disease?, Am J Respir Crit Care Med, 151, 1649, 10.1164/ajrccm/151.5_Pt_1.1649
Mannino, 2007, Global burden of COPD: risk factors, prevalence, and future trends, Lancet, 370, 765, 10.1016/S0140-6736(07)61380-4
Khreis, 2017, Exposure to traffic-related air pollution and risk of development of childhood asthma: a systematic review and meta-analysis, Environ Int, 100, 1, 10.1016/j.envint.2016.11.012
Garcia-Aymerich, 2007, Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study, Am J Respir Crit Care Med, 175, 458, 10.1164/rccm.200607-896OC
Garcia-Aymerich, 2006, Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study, Thorax, 61, 772, 10.1136/thx.2006.060145
Verlato, 2016, Smoking and new-onset asthma in a prospective study on Italian adults, Int Arch Allergy Immunol, 170, 149, 10.1159/000446509
Polosa, 2016, Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes, Discov Med, 21, 99
Wong, 2008, Childhood asthma epidemiology: insights from comparative studies of rural and urban populations, Pediatr Pulmonol, 43, 107, 10.1002/ppul.20755
Strachan, 2000, Family size, infection and atopy: the first decade of the ‘hygiene hypothesis’, Thorax, 55, S2, 10.1136/thorax.55.suppl_1.S2
Douwes, 2002, Asthma and the westernization ‘package’, Int J Epidemiol, 31, 1098, 10.1093/ije/31.6.1098
Guibas, 2013, The obesity-asthma link in different ages and the role of body mass index in its investigation: findings from the Genesis and Healthy Growth Studies, Allergy, 68, 1298, 10.1111/all.12245
Antó, 2010, Risk factors of new-onset asthma in adults: a population-based international cohort study, Allergy, 65, 1021, 10.1111/j.1398-9995.2009.02301.x
Fuchs, 2017, Asthma transition from childhood into adulthood, Lancet Respir Med, 5, 224, 10.1016/S2213-2600(16)30187-4